Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9Erectile Dysfunction 8Sexuality 2Sexual Dysfunction, Physiological 2Urinary Bladder Neoplasms 1Radiation Injuries 1Postoperative Complications 1Penile Neoplasms 1Infertility 1Erectile Dysfunction Following Radical Prostatectomy 1Carcinoma, Renal Cell 1

Interventions

Cisplatin 6pembrolizumab 5fludarabine 5Nivolumab 5Cyclophosphamide 5aldesleukin 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Ifosfamide 4Radiotherapy 3Ipilimumab 3fludarabine phosphate 2entinostat 2cabozantinib 2avelumab 2aflibercept 2Specimen Handling 2CTLA-4 Antigen 2Biopsy 2Adoptive Transfer 2vinflunine 1toripalimab 1rocakinogene sifuplasmid 1ripretinib 1oncogene protein E7, Human papillomavirus type 16 1niraparib 1nimotuzumab 1lenvatinib 1enfortumab vedotin 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Penile Neoplasms × Sildenafil Citrate × Genitourinary × Clear all
NCT00955929 2021-11-10

Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
76 enrolled 9 charts
Genitourinary

Erectile Dysfunction, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡